comparemela.com

Latest Breaking News On - Market authorization application - Page 1 : comparemela.com

Autolus reports Q1 2024 Financial Results | Company Announcement

Ocugen Provides Business Update with First Quarter 2024 Financial Results

Ocugen Provides Business Update with First Quarter 2024 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Shankar-musunuri
Exchange-commission
Linkedin
Head-of-communications
Ocugen-inc
Provides-business-update
First-quarter
License-application
Market-authorization-application
Chief-executive-officer
Luminance-dependent-navigation-assessment

Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results

Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results
balticbusinessnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from balticbusinessnews.com Daily Mail and Mail on Sunday newspapers.

Japan
Beijing
China
Kyoto
Shanghai
Hong-kong
Chinese
Asia-pacific
Brii-bio
Briana-johns
Zhi-hong
Therapeutics-inc

ExCellThera to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare Conference and to Participate in Upcoming Investor Conferences

ExCellThera to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare Conference and to Participate in Upcoming Investor Conferences
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Montreal
Quebec
Canada
United-states
San-francisco
California
Sarah-ellinwood
David-millette
Health-canada
Linkedin
European-medicines-agency
Hilton-union-square

Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results

First patient dosed in a PEG-IFN-α controlled BRII-835 + PEG-IFN-α combination Phase 2 study for HBV functional cure First of several studies to investigate the potential of BRII-179 in.

China
Hong-kong
Beijing
Shanghai
Brii-bio
Asia-pacific
Nasdaq
Brii-biosciences
National-medical-products-administration
Vir-biotechnology-inc
Prnewswire-brii-biosciences-limited-bio
Drug-administration

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.